🚨 Take Action: Support Innovation in Transplant Care Advancing care for transplant recipients depends on continued innovation—and there’s an important opportunity to help right now. We’re asking you to contact your members of Congress and urge their support for next-generation immunosuppressive therapies. Specifically, lawmakers are being asked to sign a Congressional letter supporting FDA consideration of the Composite Biomarker Panel (iBox) as a reasonably likely surrogate endpoint for kidney transplant clinical trials. It only takes a few minutes to make your voice heard. Visit our website to contact your representatives today. Your advocacy matters — and it can help drive meaningful progress for patients and the future of transplantation. 👉 Take Action: myast.org/take-action#/12
